Nuvectis Pharma (NVCT)

Nuvectis Pharma (NVCT) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• NVCT last traded at $19.18, 3.79% on the day.
• Nuvectis Pharma: P/E -14.6.
• Over the past year NVCT returned 185.84%; year to date 154.04%.

Updated 2026-11-03 13:26 UTC